Scientists at the University of Glasgow have discovered a process to trigger the death of cancer cells that could be more effective than current methods. The new method of killing cancer cells – called Caspase Independent Cell Death (CICD), and published today in Nature Cell Biology, led to the complete eradication of tumours in experimental models. Currently most...
Category: <span>Cancer</span>
Adipose tissue may affect cancer development in multiple ways
Review indicates need to further explore relationship between fat, cancer Adipose tissue, or fat, may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body, outlines new research in Cancer Prevention Research, a journal of the American Association for Cancer Research. The main author is Cornelia...
Personalised cancer treatment
In Norway, more and more people are being affected by cancer of the mouth and throat. In recent years, the incidence has increased but the mortality has remained the same. Cisplatin is one of the most commonly administered cytostatics for this patient group. At the start of treatment, the drug works well. Gradually, though, most...
Cancer: Novel cell death technique may be better than chemo
Chemotherapy, radiotherapy, and immunotherapy are typically used to treat cancer, but they do not work for all patients with the disease. In a new study, scientists have discovered a cancer-killing technique that might be more effective than conventional cancer therapies. Researchers have discovered a potentially more effective way to kill cancer cells. Researchers reveal...
How a simple ethanol injection could revolutionize some cancer treatments
Scientists have known for some time that ethanol can kill cancer cells, but several limitations held it back from becoming a broadly used treatment. A team at Duke University has recently developed a new type of ethanol solution that can be injected directly into a variety of tumors to potentially offer a new, safe, and...
Anti-inflammatory therapy cuts risk of lung cancer
In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique opportunity: to explore the effectiveness of giving a drug to patients before cancer emerges. At the European Society of Cardiology meeting, Paul M. Ridker, MD, director of the...
Nutlin-3, a p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment
Nasopharyngeal carcinoma (NPC) is a common epithelial squamous cell head and neck cancer which is strongly associated with gamma herpes Epstein-Barr virus infection and the intake of salted fish. NPC incidence remain significantly high among men in the populations of Southern China, Hong Kong, Taiwan, Northern Africa and Southeast Asia. It has claimed many thousands...
VCP protein inhibitor found to help virus kill liver tumors
Medical Xpress)—A team of researchers with members from several institutions in China has found that combining a VCP protein inhibitor with a virus that naturally targets liver cancer tumors made the virus much more potent. In their paper published in the journal Science Translational Medicine, the group describes their search for a way to improve the...
Delivering medicine to cancer cells while protecting healthy cells
Cancer treatments, including chemotherapy, have helped many people with the disease to live healthy lives. Nevertheless, chemotherapy takes a toll on the body. During treatment, chemotherapy attacks all of the body’s cells, not just cancer cells. The result destroys healthy cells, causing many patients to suffer major side effects during and after treatment. And because...
Cancer Immunotherapy: Fighting fire with fire
We, as humans, tend to idealize that which is bigger, better, faster, and stronger. It is in our nature to strive towards the best. To improve. To win. Indeed, the penetrance of this mentality reaches to our very core, even to the individual cells of which we are composed. A prime example of this: cancer....